Download Citation
Article Source:
Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines
Nishida-Fukuda H,
Tokuhiro K,
Ando Y,
Matsushita H,
Wada M,
et al.
(2021)
Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines.
PLOS ONE 16(4): e0249912.
https://doi.org/10.1371/journal.pone.0249912